サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1435308

セルベースアッセイの世界市場レポート 2024

Cell Based Assays Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
セルベースアッセイの世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

セルベースアッセイの市場規模は、今後数年間で急速に成長すると予想されています。 2028年には11.7%の年間複合成長率（CAGR）で418億6,000万米ドルに成長すると予想されます。予測期間に予想される成長は主に、AIと機械学習の統合、規制状況の変化、ハイコンテンツスクリーニングの需要の増加、疾患モデリングの進歩、精密医療への注力によるものです。この期間の主な動向には、ハイスループットスクリーニング（HTS）の採用、3D細胞培養の利用、オルガンオンチップ技術の実装、CRISPR/Cas9技術の応用、およびイメージング技術の進歩が含まれます。

調査における細胞ベースのアレイの利用は増加傾向にあり、最終段階の失敗を軽減するために、創薬においてより予測性の高い細胞モデルへの移行が必要となっています。医薬品を効果的に市場に投入し、コストのかかる後期段階での失敗を軽減するという製薬業界の責務は、セルベースアッセイの革新における重要な推進力です。新薬治験（IND）の第III相臨床試験の失敗は、企業にとって数億米ドルに達する多大な経済的損失をもたらす可能性があります。シグマの報告書は、現在の後期段階の失敗率を考慮すると、製薬会社の投資収益率は5%まで急落する可能性があり、これはほとんどの企業にとって容認できないレベルであると示しています。ハイコンテントシステムとセルベースアッセイにおけるデータ分析の大幅な機能強化により、科学者は細胞反応に関するより多くの情報を抽出できるようになり、創薬における十分な情報に基づいた意思決定が支援され、細胞ベースのアレイ市場の成長がさらに促進されます。

予想される生物製剤の売上増加は、セルベースアッセイ市場を前進させることになるでしょう。ワクチン、血液成分、遺伝子治療、治療用タンパク質など、生物由来の医薬品を含む生物製剤は、機能、効力、安全性、生物学的類似性を評価するためにセルベースアッセイに依存しています。たとえば、2023年にカナダ政府は、2021年の生物製剤の売上高が110億米ドルを超えたと報告しました。電子決済の急増もセルベースアッセイ市場の牽引役となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のセルベースアッセイ市場、製品およびサービス別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 消耗品
  • 機器
  • サービス
  • ソフトウェア
  • 世界のセルベースアッセイ市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 自動処理
  • フローサイトメトリー
  • ラベルフリーの検出
  • ハイスループットスクリーニング
  • その他の技術
  • 世界のセルベースアッセイ市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 創薬
  • 基礎調査
  • ADME研究
  • 予測毒性学
  • その他の用途
  • 世界のセルベースアッセイ市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 製薬会社およびバイオテクノロジー会社
  • 学術および政府の研究機関
  • 受託研究機関（CRO）
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界のセルベースアッセイ市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のセルベースアッセイ市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • セルベースアッセイ市場の競合情勢
  • セルベースアッセイ市場の企業プロファイル
    • F. Hoffmann-La Roche Ltd.
    • Merck &Co. Inc.
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Becton, Dickinson and Company

第31章 その他の大手および革新的な企業

  • GE HealthCare Technologies Inc.
  • Corning Incorporated
  • Lonza Group Ltd.
  • Charles River Laboratories International Inc.
  • PerkinElmer Inc.
  • Sigma-Aldrich Corporation
  • Bio-Rad Laboratories Inc.
  • Miltenyi Biotec GmbH
  • Abcam plc
  • BioVision Inc.
  • Promega Corporation
  • Caliper Life Sciences Inc.
  • Cell Signaling Technology Inc.
  • BioTek Instruments Inc.
  • Enzo Life Sciences Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r15022

Cell-based assays are experimental tools designed for studying reactions occurring inside cells, allowing researchers to investigate various mechanisms and processes related to cellular function.

The main products and services associated with cell-based assays include consumables, instruments, services, and software. Consumables are items that are used up or depleted during their usage. Instruments commonly used in cell-based assays encompass microplates, microplate readers, high-throughput screening systems, and liquid handling systems. Various consumables essential for these assays include reagents and media, cells and cell lines, probes, and labels. Cell-based assays employ different technologies, such as automated handling, flow cytometry, label-free detection, high-throughput screening, among others. These assays find applications in drug discovery, basic research, ADME (Absorption, Distribution, Metabolism, and Excretion) studies, predictive toxicology, and other research purposes. End-users of cell-based assays include pharmaceutical and biotechnology companies, academic and government research institutes, contract research organizations (CROs), and others.

The cell-based assays market research report is one of a series of new reports from The Business Research Company that provides cell-based assays market statistics, including cell-based assays industry global market size, regional shares, competitors with a cell-based assays market share, detailed cell-based assays market segments, market trends, and opportunities, and any further data you may need to thrive in the cell-based assays industry. This cell-based assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell based assays market size has grown strongly in recent years. It will grow from $24.61 billion in 2023 to $26.9 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth observed during the historic period in the field of cell-based assays can be attributed to several factors, including the emergence of high-throughput screening (HTS) techniques, the integration of automation, the utilization of biomarker detection methods, the adoption of microfluidics, and the introduction of gene editing tools.

The cell based assays market size is expected to see rapid growth in the next few years. It will grow to $41.86 billion in 2028 at a compound annual growth rate (CAGR) of 11.7%. The growth expected in the forecast period is primarily due to the integration of AI and machine learning, a shift in the regulatory landscape, increased demand for high-content screening, advancements in disease modeling, and a focus on precision medicine. Key trends during this period include the adoption of high-throughput screening (HTS), the utilization of 3D cell cultures, the implementation of organ-on-a-chip technology, the application of CRISPR/Cas9 technology, and progress in imaging techniques.

The utilization of cell-based arrays in research is on the rise, necessitating a shift towards more predictive cellular models in drug discovery to mitigate last-stage failures. The pharmaceutical industry's imperative to effectively bring drugs to market and mitigate costly late-stage failures is a key driver in the innovation of cell-based assays. Failure in Phase III clinical trials of investigational new drugs (IND) can result in substantial financial losses, reaching several hundred million dollars for the company. Sigma's report indicates that the return on investment for pharmaceutical companies could plummet to 5% given the current rate of late-stage failures, an unacceptable level for most companies. Significant enhancements in high-content systems and data analysis in cell-based assays empower scientists to extract more information about cellular responses, aiding informed decision-making in drug discovery and further fueling the growth of the cell-based array market.

The anticipated increase in biologics sales is set to propel the cell-based assays market forward. Biologics, encompassing medicines derived from living organisms, including vaccines, blood components, gene therapies, and therapeutic proteins, rely on cell-based assays for evaluating functionality, potency, safety, and bio-similarity. For example, in 2023, the Government of Canada reported biologics sales exceeding $11 billion in 2021. The surge in electronic payment methods is also contributing to the drive in the cell-based assays market.

The primary factor constraining the global cell-based assay market is the high cost of instruments. The elevated prices of instrumentation can diminish the return on investments (ROI) due to low adaptation. Biotek's development of HCA (high content analysis) instruments, while advanced, comes with a high price tag, limiting accessibility to industrial end-users or core labs with sufficient capital budgets. This restriction prevents low-budget end-users from fully leveraging cell-based assays, thereby impeding market growth.

Researchers are increasingly leaning towards early-phase predictive toxicity testing to avert late-stage drug failures. The scaling up of predictive cell toxicity assays aims to increase compound screening in the early stages of drug development, reducing the cost of failure. For instance, Creative Bioarray, a biotech company, offers a range of in vitro toxicity services to assess drug-induced toxicities, saving time and costs by minimizing the risk of failure in earlier stages. These advancements aim to simplify clinical testing and reduce operational costs.

Leading companies in the cell-based assays market are introducing new platforms, such as cell-based phenotypic assay platforms, to provide advanced solutions for drug discovery. A cell-based phenotypic assay platform is a system in drug discovery that evaluates cellular responses to compound treatments by integrating advanced imaging and analytical tools, powered by artificial intelligence. In February 2021, Selvita, a Poland-based biotechnology company, launched a new cell-based phenotypic assay platform for drug discovery, targeting areas such as neuroinflammatory and fibrotic diseases. This advanced platform integrates high-content imaging systems with artificial intelligence to enhance drug profiling and mechanism of action studies, aiming to expedite the drug discovery process. The platform enhances Selvita's offerings for pharmaceutical and biotech companies looking to leverage AI in drug discovery.

In May 2022, Cell Carta, a Canada-based provider of precision medicine laboratory services, acquired next-generation immune-MRM assays from Precision Assays for an undisclosed amount. This acquisition aims to strengthen Cell Carta's position in the proteomics vertical and enhance its service offerings in precision medicine laboratory services. Precision Assays, a US-based provider of next-generation targeted proteomics testing solutions, played a significant role in this strategic move.

Major companies operating in the cell based assays market report are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Corning Incorporated, Lonza Group Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., Miltenyi Biotec GmbH, Abcam PLC, BioVision Inc., Promega Corporation, Caliper Life Sciences Inc., Cell Signaling Technology Inc., BioTek Instruments Inc., Enzo Life Sciences Inc., BioAgilytix Labs LLC, Cisbio International LLC, ProQinase GmbH, QGel SA, Biotium Inc., Selexis SA, Aurelia Bioscience Ltd., Creative Bioarray, Cell Biolabs Inc., Essen BioScience Ltd., Eurofins Scientific SE, DiscoveRx Corporation

North America was the largest region in the cell-based assays market in 2023. Western Europe was the second largest region in the global cell-based assays market share. The regions covered in the cell based assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell based assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cell-based assay market consists of sales of reagents, cell lines, microplates, microplates, assay kits, probes, and labels. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Based Assays Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell based assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell based assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell based assays market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product & Service: Consumables; Instruments; Services; Software
  • 2) By Technology: Automated Handling; Flow Cytometry; Label-Free Detection; High-Throughput Screening; Other Technologies
  • 3) By Application: Drug Discovery; Basic Research; ADME Studies; Predictive Toxicology; Other Applications
  • 4) By End User: Pharmaceutical And Biotechnology Companies; Academic And Government Research Institutes; Contract Research Organizations (CRO); Other End Users

Sub-segments

  • By Instruments: Microplates; Microplate Readers; High Throughput Screening; Liquid Handling Systems
  • By Consumables: Reagents And Media; Cells And Cell Lines; Probes And Labels
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Danaher Corporation; Becton, Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell Based Assays Market Characteristics

3. Cell Based Assays Market Trends And Strategies

4. Cell Based Assays Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Cell Based Assays Market Size and Growth

  • 5.1. Global Cell Based Assays Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cell Based Assays Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cell Based Assays Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cell Based Assays Market Segmentation

  • 6.1. Global Cell Based Assays Market, Segmentation By Product & Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Consumables
  • Instruments
  • Services
  • Software
  • 6.2. Global Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Automated Handling
  • Flow Cytometry
  • Label-Free Detection
  • High-Throughput Screening
  • Other Technologies
  • 6.3. Global Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Discovery
  • Basic Research
  • ADME Studies
  • Predictive Toxicology
  • Other Applications
  • 6.4. Global Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Academic And Government Research Institutes
  • Contract Research Organizations (CRO)
  • Other End Users

7. Cell Based Assays Market Regional And Country Analysis

  • 7.1. Global Cell Based Assays Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cell Based Assays Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cell Based Assays Market

  • 8.1. Asia-Pacific Cell Based Assays Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cell Based Assays Market

  • 9.1. China Cell Based Assays Market Overview
  • 9.2. China Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cell Based Assays Market

  • 10.1. India Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cell Based Assays Market

  • 11.1. Japan Cell Based Assays Market Overview
  • 11.2. Japan Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cell Based Assays Market

  • 12.1. Australia Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cell Based Assays Market

  • 13.1. Indonesia Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cell Based Assays Market

  • 14.1. South Korea Cell Based Assays Market Overview
  • 14.2. South Korea Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cell Based Assays Market

  • 15.1. Western Europe Cell Based Assays Market Overview
  • 15.2. Western Europe Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cell Based Assays Market

  • 16.1. UK Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cell Based Assays Market

  • 17.1. Germany Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cell Based Assays Market

  • 18.1. France Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cell Based Assays Market

  • 19.1. Italy Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cell Based Assays Market

  • 20.1. Spain Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cell Based Assays Market

  • 21.1. Eastern Europe Cell Based Assays Market Overview
  • 21.2. Eastern Europe Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cell Based Assays Market

  • 22.1. Russia Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cell Based Assays Market

  • 23.1. North America Cell Based Assays Market Overview
  • 23.2. North America Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cell Based Assays Market

  • 24.1. USA Cell Based Assays Market Overview
  • 24.2. USA Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cell Based Assays Market

  • 25.1. Canada Cell Based Assays Market Overview
  • 25.2. Canada Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cell Based Assays Market

  • 26.1. South America Cell Based Assays Market Overview
  • 26.2. South America Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cell Based Assays Market

  • 27.1. Brazil Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cell Based Assays Market

  • 28.1. Middle East Cell Based Assays Market Overview
  • 28.2. Middle East Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cell Based Assays Market

  • 29.1. Africa Cell Based Assays Market Overview
  • 29.2. Africa Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cell Based Assays Market Competitive Landscape And Company Profiles

  • 30.1. Cell Based Assays Market Competitive Landscape
  • 30.2. Cell Based Assays Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck & Co. Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Danaher Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Becton, Dickinson and Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Cell Based Assays Market Other Major And Innovative Companies

  • 31.1. GE HealthCare Technologies Inc.
  • 31.2. Corning Incorporated
  • 31.3. Lonza Group Ltd.
  • 31.4. Charles River Laboratories International Inc.
  • 31.5. PerkinElmer Inc.
  • 31.6. Sigma-Aldrich Corporation
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. Miltenyi Biotec GmbH
  • 31.9. Abcam plc
  • 31.10. BioVision Inc.
  • 31.11. Promega Corporation
  • 31.12. Caliper Life Sciences Inc.
  • 31.13. Cell Signaling Technology Inc.
  • 31.14. BioTek Instruments Inc.
  • 31.15. Enzo Life Sciences Inc.

32. Global Cell Based Assays Market Competitive Benchmarking

33. Global Cell Based Assays Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cell Based Assays Market

35. Cell Based Assays Market Future Outlook and Potential Analysis

  • 35.1 Cell Based Assays Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Cell Based Assays Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Cell Based Assays Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer